Organ Preservation Market
By Solution;
University of Wisconsin Solution, Custodial HTK, Perfadex, and Other SolutionsBy Technique;
Static Cold Storage, Hypothermic Machine Perfusion, and Normothermic Machine PerfusionBy Organ Type;
Kidney, Liver, Lung, Heart, and PancreasBy End User;
Organ Transplant Centers, Hospitals, and Specialty ClinicsBy Geography;
North America, Europe, Asia Pacific, Middle East & Africa and Latin America - Report Timeline (2021 - 2031)Organ Preservation Market Overview
Organ Preservation Market (USD Million)
Organ Preservation Market was valued at USD 2,293.03 million in the year 2024. The size of this market is expected to increase to USD 3,568.02 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.5%.
Organ Preservation Market
*Market size in USD million
CAGR 6.5 %
| Study Period | 2025 - 2031 |
|---|---|
| Base Year | 2024 |
| CAGR (%) | 6.5 % |
| Market Size (2024) | USD 2,293.03 Million |
| Market Size (2031) | USD 3,568.02 Million |
| Market Concentration | Medium |
| Report Pages | 396 |
Major Players
- XVIVO Perfusion AB
- Organ Recovery Systems, Inc
- Preservation Solutions, Inc
- TransMedics, Inc
- Waters Medical Systems LLC
- OrganOx Limited
- Bridge to Life Ltd
- OrganAssist BV
- Essential Pharmaceuticals LLC
- 21st Century Medicine Inc
Market Concentration
Consolidated - Market dominated by 1 - 5 major players
Organ Preservation Market
Fragmented - Highly competitive market without dominant players
Organ preservation market is seeing remarkable growth, driven by cutting-edge advancements in transplantation technology and a rise in the number of transplant surgeries conducted worldwide. Organ preservation plays a vital role in maintaining the viability and functionality of donor organs during transportation and pre-transplant phases, which significantly enhances patient outcomes and reduces the risk of organ rejection. Among the most widely used preservation methods, cold storage dominates with around 65% of usage, followed by hypothermic machine perfusion at 20%, and the emerging normothermic machine perfusion technique, which accounts for approximately 10–15%. These preservation techniques offer specific advantages tailored to various organ types and medical requirements.
Factors Driving Market Growth
The main driver of this market expansion is the growing incidence of end-stage organ failure, largely attributed to aging populations and a rise in chronic lifestyle-related conditions like diabetes, hypertension, and obesity. Approximately 10% of people worldwide are affected by chronic kidney disease, a leading cause of organ transplant demand. Currently, donor organ availability meets only 10–15% of the global demand for transplants, resulting in a critical shortage. This gap is amplifying the need for advanced organ preservation technologies, which can extend organ viability by 30–50% over traditional methods. These innovations are helping to increase the pool of organs that are viable for transplantation.
Government Initiatives and Investments
In addition to medical advancements, government policies and initiatives are playing a key role in accelerating market growth. Programs designed to raise awareness about organ donation and streamline transplantation systems have led to notable improvements. For example, organ donation registration rates have increased by 25–30% in regions that have implemented comprehensive awareness campaigns. Partnerships between healthcare providers, transplant centers, and regulatory bodies are enhancing organ procurement systems, allocation processes, and overall transplant success rates. Furthermore, increased investments from major industry players are driving research and development, with expected annual increases in R&D spending of 18–22%. These efforts are contributing to the development of next-generation preservation technologies that will improve access to transplantation services and address critical unmet needs in the global healthcare system.
Organ Preservation Market Key Takeaways
-
Organ preservation market is driven by rising global transplant volumes, increasing demand for high-quality grafts and the ongoing need to maintain optimal organ viability from retrieval to implantation.
-
Cold storage solutions remain widely used for kidney, liver and heart transplants, while growing clinical preference for machine perfusion systems is improving organ quality and extending preservation times.
-
Expanding adoption of hypothermic and normothermic perfusion supports the usage of marginal and extended-criteria donors by reducing ischemic injury and enhancing post-transplant outcomes.
-
Manufacturers are advancing oxygenated preservation fluids, temperature-controlled devices and organ-specific solutions to enhance compatibility and performance across different transplant procedures.
-
Stronger emphasis on evidence-based protocols and updated clinical guidelines is shaping technology selection, validation requirements and best practices for transplant teams worldwide.
-
High costs associated with advanced perfusion technologies remain a barrier for some centers, encouraging hybrid adoption models that combine conventional cold storage with targeted use of perfusion systems.
-
Growing collaboration between device manufacturers, solution developers and transplant networks is accelerating training, real-world evidence generation and broader acceptance of innovative preservation methods.
Organ Preservation Market Recent Developments
-
In August 2024, Getinge completed the acquisition of Paragonix Technologies to expand its organ preservation capabilities.
-
In August 2025, Terumo Medical Corporation announced the acquisition of OrganOx to strengthen its organ-preservation technology portfolio.
Organ Preservation Market Segment Analysis
In this report, the Organ Preservation Market has been segmented by Solution, Technique, Organ Type, End User and Geography. These axes capture evolving trends in preservation fluids, perfusion technologies and transplant-center practices that directly influence graft quality, cold-ischemia times and post-transplant outcomes. Increasing transplant volumes, donor pool expansion initiatives and innovation in machine perfusion platforms are central to the market’s long-term growth outlook.
Organ Preservation Market, Segmentation by Solution
The Solution segmentation focuses on preservation fluids formulated to maintain cellular integrity and metabolic stability during storage and transport. Selection of solutions is guided by organ-specific protocols, center preferences and clinical-evidence strength. As transplant programs aim to improve graft survival and reduce complications, interest in optimized and next-generation preservation solutions continues to rise.
University of Wisconsin SolutionUniversity of Wisconsin solution remains a reference standard for abdominal organ preservation, especially in liver and pancreas transplantation. Its composition supports osmotic balance, reduced cellular swelling and protection against cold ischemia, making it widely embedded in transplant-center protocols. Ongoing clinical experience reinforces its use in high-risk and extended-criteria donor scenarios.
Custodial HTKCustodial HTK is valued for its low-viscosity profile and suitability for multi-organ flushing, particularly in heart and kidney transplantation. Transplant teams appreciate its ability to facilitate rapid organ cooling and efficient distribution through the microcirculation. Usage patterns are influenced by institutional protocols, surgeon preference and procurement network practices.
PerfadexPerfadex is primarily associated with lung preservation, supporting optimal oxygenation and microvascular protection during cold storage and transport. Its formulation helps maintain pulmonary endothelial integrity, which is critical for post-implant function and early graft performance. Adoption is strengthened by growing lung-transplant volumes and the rise of ex vivo lung perfusion platforms.
Other SolutionsOther solutions include regionally preferred formulations and emerging products tailored to specific organ types or perfusion strategies. These may focus on improved buffering capacity, antioxidant protection or compatibility with machine-perfusion systems. As comparative effectiveness data accumulates, transplant centers evaluate these alternatives to refine their preservation protocols.
Organ Preservation Market, Segmentation by Technique
The Technique segmentation reflects the transition from traditional static storage to dynamic perfusion methods that better mimic physiological conditions. Hospitals increasingly balance cost considerations with the potential for improved graft function, especially in marginal and extended-criteria donor organs. This shift is gradually redefining organ-allocation decisions and logistics planning across transplant networks.
Static Cold StorageStatic cold storage remains the most widely used technique due to its simplicity, established outcomes and compatibility with existing logistics. Packed-ice and cold-solution protocols provide reliable short-duration preservation for many standard-risk donors. Despite increasing interest in machine perfusion, static cold storage continues to dominate routine kidney and liver transplantation workflows.
Hypothermic Machine PerfusionHypothermic machine perfusion delivers cold, oxygenated solution through the organ to maintain perfusion under controlled conditions. It is increasingly adopted to improve graft viability, especially for marginal kidneys and livers, while enabling better assessment prior to implantation. Centers adopting this technique focus on reducing delayed graft function and improving long-term survival metrics.
Normothermic Machine PerfusionNormothermic machine perfusion maintains organs at near-physiological temperature with oxygenated blood or blood-like perfusates. This approach allows real-time functional assessment, targeted pharmacologic interventions and potential organ repair before transplantation. Although capital-intensive, its use is expanding in high-volume programs seeking to maximize utilization of high-risk donor organs.
Organ Preservation Market, Segmentation by Organ Type
The Organ Type segmentation underscores differing preservation requirements and logistical constraints associated with each transplanted organ. Cold-ischemia tolerance, susceptibility to reperfusion injury and donor-recipient matching drive protocol selection. As organ demand continues to outpace supply, strategies to extend preservation windows and enhance marginal organ utilization are becoming increasingly important.
KidneyKidney transplantation constitutes a large portion of global transplant activity, relying heavily on static cold storage complemented by selective use of hypothermic machine perfusion. Preservation strategies aim to minimize delayed graft function and support organs from expanded-criteria and donation-after-circulatory-death donors. Growing adoption of machine perfusion technologies reflects efforts to improve long-term renal outcomes.
LiverLiver preservation is more time-sensitive, with a narrower tolerance for extended cold-ischemia times. Use of specialized solutions and growing uptake of dual perfusion or normothermic perfusion systems are central to managing complex and marginal grafts. Advanced preservation techniques support broader use of split livers, living donors and steatotic organs.
LungLung preservation requires careful control of vascular and airway conditions to prevent edema and maintain gas-exchange capacity. Perfadex-based protocols and ex vivo lung perfusion platforms help optimize post-transplant function, particularly for high-risk donors. As lung-transplant programs expand, demand for refined preservation techniques continues to accelerate.
HeartHeart transplantation remains highly time-critical, traditionally dependent on rapid static cold storage. Emerging portable normothermic perfusion systems allow continuous beating-heart perfusion, extending viable transport times and enabling better functional assessment. These advances help increase donor-heart utilization and support longer-distance organ sharing.
PancreasPancreas preservation is crucial for successful islet and whole-organ transplantation in diabetes management. Protocols prioritize protection against enzymatic autodigestion and vascular damage during cold storage. Growing focus on islet transplantation and combined kidney-pancreas procedures is influencing refinement of pancreas-specific preservation strategies.
Organ Preservation Market, Segmentation by End User
The End User segmentation highlights where preservation solutions and technologies are deployed within the transplant ecosystem. Organ transplant centers, general hospitals and specialty clinics each play distinct roles in organ retrieval, storage and implantation. Their purchasing decisions are shaped by transplant volume, available infrastructure, staffing expertise and participation in advanced clinical programs.
Organ Transplant CentersOrgan transplant centers serve as primary hubs for advanced preservation techniques, including machine perfusion and tailored solution protocols. These centers drive adoption of innovative technologies, participate in clinical trials and set practice benchmarks for regional networks. Their high procedure volumes necessitate robust logistics and standardized preservation workflows.
HospitalsHospitals without full transplant programs may still be involved in donor management, organ retrieval and interim storage before transfer to transplant centers. They rely on dependable cold-storage practices and standardized solutions that integrate seamlessly with procurement organizations. Training and protocol adherence are critical to maintaining organ quality across the referral chain.
Specialty ClinicsSpecialty clinics, including those focused on pre- and post-transplant care, play a growing role in optimizing patients before listing and following them after surgery. While they typically do not perform organ storage, their engagement with transplant programs influences overall demand for high-quality grafts and advanced preservation strategies. Coordination between clinics and transplant centers is essential for long-term outcome monitoring.
Organ Preservation Market, Segmentation by Geography
The Geography segmentation reflects regional differences in transplant infrastructure, donor-availability initiatives, regulatory frameworks and funding mechanisms. Established transplant regions show high uptake of advanced perfusion technologies, while emerging markets focus on strengthening logistics and standardizing cold-storage practices. Cross-border collaboration and organ-sharing agreements also shape technology and solution adoption patterns.
Regions and Countries Analyzed in this Report
North America leads in organ preservation innovation, supported by high transplant volumes, well-developed procurement organizations and strong funding for machine-perfusion research. Regional networks emphasize extended-criteria donor utilization and cross-center protocol harmonization, driving demand for advanced solutions.
EuropeEurope demonstrates robust adoption of preservation fluids and perfusion technologies, guided by coordinated transplant registries and cross-border sharing frameworks. Emphasis on evidence-based practice and standardized training supports continued refinement of preservation strategies across organ types.
Asia PacificAsia Pacific is experiencing rapid growth as transplant programs expand and infrastructure investments increase. Leading centers are beginning to incorporate hypothermic and normothermic perfusion for high-risk organs, while many institutions still rely predominantly on static cold storage. Government initiatives to build donor pools are expected to further stimulate demand.
Middle East & AfricaMiddle East & Africa remains at a developing stage for organ preservation, with select countries operating advanced transplant centers. Investments in specialized training, donor-organization frameworks and cold-chain logistics are key priorities. Gradual adoption of newer technologies is anticipated as capacity and expertise expand.
Latin AmericaLatin America shows steady progress in transplant activity, with growing interest in enhancing preservation practices beyond conventional cold storage. Collaboration with international societies and reference centers supports knowledge transfer and early evaluation of machine-perfusion options, particularly in higher-volume urban hospitals.
Organ Preservation Market Forces
This report provides an in depth analysis of various factors that impact the dynamics of Organ Preservation Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Comprehensive Market Impact Matrix
This matrix outlines how core market forces Drivers, Restraints and Opportunities affect key business dimensions including Growth, Competition, Customer Behavior, Regulation and Innovation.
| Market Forces ↓ / Impact Areas → | Market Growth Rate | Competitive Landscape | Customer Behavior | Regulatory Influence | Innovation Potential |
|---|---|---|---|---|---|
| Drivers | High impact (e.g., tech adoption, rising demand) | Encourages new entrants and fosters expansion | Increases usage and enhances demand elasticity | Often aligns with progressive policy trends | Fuels R&D initiatives and product development |
| Restraints | Slows growth (e.g., high costs, supply chain issues) | Raises entry barriers and may drive market consolidation | Deters consumption due to friction or low awareness | Introduces compliance hurdles and regulatory risks | Limits innovation appetite and risk tolerance |
| Opportunities | Unlocks new segments or untapped geographies | Creates white space for innovation and M&A | Opens new use cases and shifts consumer preferences | Policy shifts may offer strategic advantages | Sparks disruptive innovation and strategic alliances |
Drivers, Restraints and Opportunity Analysis
Drivers:
- Growing global elderly population
- Critical shortage of donor organs
- Breakthroughs in preservation technologies
- Rise in organ transplant procedures
-
Surge in chronic disease cases - Organ preservation market is experiencing significant growth, largely due to the increasing prevalence of chronic diseases across the world. Conditions like cardiovascular diseases, diabetes, kidney failure, and liver diseases are on the rise, often attributed to factors such as unhealthy diets, sedentary lifestyles, and aging populations. These diseases frequently lead to organ failure, which creates a greater demand for organ transplants as a life-saving treatment. As the demand for organs outpaces the availability of suitable donors, advanced organ preservation technologies play a crucial role in maintaining organ viability during transportation and storage, improving the likelihood of successful transplants. This growing need for effective preservation solutions is spurring innovation and investment, which has led to the development of more efficient preservation techniques and devices that enhance organ quality and transplant outcomes.
Medical technology and research advancements have revolutionized organ preservation, facilitating the development of new techniques that extend preservation times and enhance organ viability. Notable innovations include machine perfusion systems hypothermic and normothermic perfusion systems that offer superior organ preservation by maintaining ideal conditions for organ function outside the body. These technologies not only increase the duration organs can be preserved but also allow for organ viability assessments prior to transplantation, thereby reducing the risks of graft failure and rejection.
The increased adoption of organ preservation technologies is also driven by the expansion of organ procurement and transplantation programs worldwide. Government initiatives, along with collaborations between healthcare organizations and research institutions, have helped address the growing demand for organs. These efforts are vital for ensuring that the right preservation methods are in place to improve transplant success rates and, ultimately, patient outcomes.With these advancements and a rising demand for organ preservation solutions, the market for organ preservation is expected to continue its rapid growth, helping meet the increasing need for organ transplants globally.
Restraints:
- Restricted organ preservation technologies available
- Complex regulatory approval hurdles
- Expensive organ preservation procedures
- Low public awareness of preservation
-
Ongoing ethical debates in transplantation - The rapid advancement of organ preservation technologies has opened new possibilities in organ transplantation, offering hope to millions of patients in need of life-saving transplants. However, this progress also brings forth significant ethical issues. One of the most pressing ethical dilemmas involves the allocation of preserved organs. Given that the demand for organs far outweighs the supply, questions about the fairness of distribution inevitably arise. Should organ allocation be based on medical urgency, the recipient's socioeconomic status, or other criteria? As the principles of justice, beneficence, and autonomy come into play, determining who should receive these limited resources becomes an increasingly complex issue.
Ethical considerations in organ preservation extend beyond the allocation process to the very methods used for organ storage and viability extension. As preservation technologies evolve to prolong organ life outside the body, they raise significant questions about the definition of death and the ethics of intervening in the natural dying process. Prolonged preservation of organs calls into question the boundaries between life and death, especially when these advancements challenge traditional views on the timing of organ donation.
Ensuring that informed consent is obtained from organ donors becomes crucial as preservation techniques continue to advance. The ethical concerns of respecting the autonomy of donors grow as the line between organ donation and the potential commodification of human body parts becomes increasingly blurred. With the expansion of the organ preservation market, addressing these ethical challenges will require ongoing conversations, transparency, and a strong commitment to ethical principles like beneficence, non-maleficence, and justice. These principles are vital to ensuring that patient outcomes are improved while upholding the dignity and rights of donors.
Opportunities:
- Emerging markets
- Development of novel preservation solutions
- Collaborations and partnerships
- Focus on personalized medicine
-
Growing medical tourism industry - Organ preservation market is witnessing substantial growth, driven primarily by advancements in medical technology and a rising global demand for organ transplantation procedures. Organ preservation solutions are essential in maintaining the viability of organs during storage and transportation, ensuring they remain suitable for transplantation. As incidents of organ failure increase, and with a growing aging population, the need for organ transplants continues to rise, further intensifying the demand for effective organ preservation methods.
The rapid expansion of the medical tourism industry is also playing a significant role in the growth of the organ preservation market. Patients from developed nations are increasingly traveling to emerging economies where affordable medical treatments, including organ transplant procedures, are available. This trend is particularly prominent in countries with lower healthcare costs but high-quality medical infrastructure and skilled healthcare professionals. As a result, the demand for advanced organ preservation solutions is anticipated to increase in regions popular for medical tourism, spurring further market growth and technological innovation.
The organ preservation market is expanding due to the synergy between technological progress, the rising need for organ transplants, and the growth of the medical tourism industry. As these factors converge, the market for organ preservation technologies is expected to see continued growth, providing innovative solutions to meet the increasing demand for organ transplants worldwide.
Organ Preservation Market Competitive Landscape Analysis
Organ Preservation Market is characterized by strong competition among established players who emphasize strategies such as collaboration, partnerships, and merger activities to enhance their market presence. Companies are focusing on innovation and advanced product development, with nearly 65% of key participants investing in technological improvements to ensure long-term growth in this critical sector.
Market Structure and Concentration
The market demonstrates moderate concentration, where nearly 55% of share is captured by a few major players. This concentration is influenced by extensive R&D investments and technological advancements in preservation techniques. Smaller firms often enter through partnerships or niche strategies, creating a balance between established dominance and innovative entrants driving expansion.
Brand and Channel Strategies
Leading companies in the organ preservation field rely on strong brand visibility and diversified distribution strategies. More than 60% of manufacturers are enhancing online and direct hospital networks to strengthen supply chains. Consistent collaboration with medical institutions and partnerships with procurement organizations are critical in driving competitive advantage and fostering sustained growth.
Innovation Drivers and Technological Advancements
With nearly 70% of industry leaders investing in R&D, technological advancements remain central to competitive edge. Developments in machine perfusion and advanced preservation solutions are reshaping the market. Companies are adopting strategies centered on product innovation and process automation, ensuring significant growth prospects while reinforcing their positions through collaboration in medical research.
Regional Momentum and Expansion
Regional leaders account for around 58% of overall market activity, with strong momentum seen in emerging healthcare hubs. Companies are expanding through targeted partnerships and joint strategies to capture demand. Focused collaboration with regional health systems has become critical, enhancing growth potential and supporting long-term expansion in underserved regions.
Future Outlook
The future of the organ preservation industry is shaped by increasing emphasis on innovation, with nearly 62% of companies planning stronger R&D integration. Continuous technological advancements, combined with strategic partnerships, will sustain competitive momentum. The market will witness consistent growth as leading players drive expansion through collaborative models and adaptive preservation strategies.
Key players in Organ Preservation Market include::
- XVIVO Perfusion AB
- TransMedics, Inc.
- Paragonix Technologies, Inc.
- Dr. Franz Köhler Chemie GmbH
- OrganOx Limited
- Bridge to Life Ltd.
- Preservation Solutions, Inc.
- Global Transplant Solutions
- Organ Recovery Systems, Inc.
- 21st Century Medicine
- BioLife Solutions, Inc.
- Waters Medical Systems LLC
- CryoLife, Inc.
- Transplant Biomedicals
- Shanghai Genext Medical Technology Co., Ltd.
In this report, the profile of each market player provides following information:
- Market Share Analysis
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Solution
- Market Snapshot, By Technique
- Market Snapshot, By Organ
- Market Snapshot, By End User
- Market Snapshot, By Region
- Organ Preservation Market Forces
- Drivers, Restraints and Opportunities
- Drivers
- Growing elderly population
- Critical shortage of donor organs
- Breakthroughs in preservation technologies
- Rise in organ transplant procedures
- Surge in chronic disease cases
- Restraints
- Restricted organ preservation technologies available
- Complex regulatory approval hurdles
- Expensive organ preservation procedures
- Low public awareness of preservation
- Ongoing ethical debates in transplantation
- Opportunities
- Emerging markets
- Development of novel preservation solutions
- Collaborations and partnerships
- Focus on personalized medicine
- Growing medical tourism industry
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Organ Preservation Market, By Solution, 2021 - 2031 (USD Million)
- University of Wisconsin Solution
- Custodial HTK
- Perfadex
- Other Solutions
- Organ Preservation Market, By Technique, 2021 - 2031 (USD Million)
- Static Cold Storage
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Organ Preservation Market, By Organ Type, 2021 - 2031 (USD Million)
- Kidney
- Liver
- Lung
- Heart
- Pancreas
- Organ Preservation Market, By End User, 2021 - 2031 (USD Million)
- Organ Transplant Centers
- Hospitals
- Specialty Clinics
- Organ Preservation Market, By Solution, 2021 - 2031 (USD Million)
- Organ Preservation Market Market, By Geography, 2021 - 2031 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Competitive Landscape
- Company Profiles
- XVIVO Perfusion AB
- TransMedics, Inc.
- Paragonix Technologies, Inc.
- Dr. Franz Köhler Chemie GmbH
- OrganOx Limited
- Bridge to Life Ltd.
- Preservation Solutions, Inc.
- Global Transplant Solutions
- Organ Recovery Systems, Inc.
- 21st Century Medicine
- BioLife Solutions, Inc.
- Waters Medical Systems LLC
- CryoLife, Inc.
- Transplant Biomedicals
- Shanghai Genext Medical Technology Co., Ltd.
- Company Profiles
- Analyst Views
- Future Outlook of the Market

